Homelessness Executive Order’s Controversy Overshadows the Positives: Katherine Koh, MD, MSc
The positive aspects of the executive order focused on homeless individuals, have been overshadowed by aspects not viewed as positively.
Watch
Smartphone App Reduces Depression in Adults With Intellectual Disabilities
A self-help app based on cognitive behavioral therapy improved depression, self-esteem, and quality of life in adults with intellectual disabilities.
Read More
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
Telemedicine improved the quality of life and inhaler technique among patients with advanced-stage chronic obstructive pulmonary disease (COPD).
Advancing Cancer Care Through Technology, Provider-Pharmacist Collaboration: Scott Soefje, PharmD, MBA, BCOP
Artificial intelligence, automation, and expanded pharmacist roles help reduce administrative burdens, improve workflow, and support providers in delivering cancer care, according to Scott Soefje, PharmD, MBA, BCOP.
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
Researchers developed a first-of-its-kind panel to track receptor expression and predict therapy response.
Novel Predictive Model May Help Identify Patients at Risk for Difficult-to-Treat RA
The study highlighted pain, fatigue, and functional status as key early warning signs.
Nanopore Sequencing Accurate in IGH Monitoring for CLL
Nanopore sequencing of chronic lymphocytic leukemia (CLL) may be a particularly good fit in under-resourced areas due to its lower cost and smaller laboratory footprint.
HRQOL Not Consistently Assessed in Studies on NSCLC Treatment Efficacy
A review found that assessing for health-related quality of life (HRQOL) was not frequently done in studies related to non–small cell lung cancer (NSCLC).
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
Early research has identified several antigens that could help facilitate the use of chimeric antigen receptor T cells in small cell lung cancer.
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
Cemiplimab has been approved as the first immunotherapy for high-risk cutaneous squamous cell carcinoma (CSCC), significantly improving disease-free survival rates.
Systemic Barriers in Patients’ Weight Loss Journey: David Rometo, MD
Social determinants of health disproportionately impact patients' ability to maintain and achieve their weight loss goals.
New Partnership Model Boosts Maternal Outcomes in Medicaid ACOs
Research reveals that Medicaid accountable care organization (ACO) designs significantly impact maternal health outcomes, highlighting the importance of structural partnerships in care delivery.
Addressing Psychosocial Barriers Key During Soft Tissue Sarcoma Surgery Recovery
Emotional well-being and social engagement significantly impact quality of life for patients with soft tissue sarcoma post-surgery.
SGLT2 Inhibitors Show Protective Effect on Kidneys
The class of diabetes drug has a protective effect on the kidneys for reasons beyond glucose control.
AI Expands Clinical Trial Access, Advances Drug Repurposing Efforts: Vivek Subbiah, MD
Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD.
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term.
ERS Recap: The Role of Empathy, Shared Decision-Making in Modern Respiratory Care
Empathy and communication strengthen patient-provider relationships and improve respiratory care outcomes, as discussed at the European Respiratory Society (ERS) Congress.
NICU Nurses More Likely to Miss Tasks Due to Increased Workload
Increased workload among nurses in the neonatal intensive care unit (NICU) may reduce the quality of care for individual infants, as certain tasks are more likely to be missed.
Weight Loss Treatment Variability and Cost-Effectiveness: David Rometo, MD
David Rometo, MD, weighs various weight loss treatments, their success, and sustainability.
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
New treatment options are needed for patients with accelerated-phase or blast-phase myeloproliferative neoplasms (MPNs) ineligible for standard care.
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment.
Addressing Common Stigmas in Weight Loss: David Rometo, MD
David Rometo, MD, of UPMC, addresses stigma surrounding obesity and group setting weight loss intervention therapies and how consults benefit patients.
Weight Loss Medications Show Promise in MASLD, MASH
Weight loss medications show promise in improving liver health for those with chronic liver conditions, a review found.
Aumolertinib Effective in Treating EGFR-Mutant NSCLC
Aumolertinib was compared against osimertinib to demonstrate its efficacy in those with mutated non-small cell lung cancer (NSCLC).
Pharmacists Strained by Time Pressures, Limited Resources in Diabetes Care
A CCS report found that pharmacists lack time for diabetes education as workloads rise, worsening disparities and threatening adherence.
New First-in-Class ITP Therapy May Transform Clinical Practice: David Kuter, MD, DPhil
Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.
Survey Reveals Clinician Confidence Around Using AI in PA Process
Prior authorizations for health plans will soon implement AI to streamline the process and potentially improve patient outcomes.
Advances in Outpatient Care Transform Delivery of Bispecific Antibodies, ADCs: Scott Soefje, PharmD, MBA, BCOP
Scott Soefje, PharmD, MBA, BCOP, discusses how remote patient monitoring and caregiver support enable safe outpatient delivery of bispecific antibodies and antibody-drug conjugates.
Contributor: Why Public Health Keeps Failing—and How to Fix It
Public health must address emotional and structural inequities, emphasizes Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health.
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
Today, Amgen announced the launch of AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at nearly 60% below the current US list price.
